167 related articles for article (PubMed ID: 20005925)
21. Melatonin in the eye: implications for glaucoma.
Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP; Rosenstein RE
Exp Eye Res; 2007 Jun; 84(6):1021-30. PubMed ID: 17174303
[TBL] [Abstract][Full Text] [Related]
22. Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways.
Yanarates O; Dogrul A; Yildirim V; Sahin A; Sizlan A; Seyrek M; Akgül O; Kozak O; Kurt E; Aypar U
Anesthesiology; 2010 Mar; 112(3):696-710. PubMed ID: 20179508
[TBL] [Abstract][Full Text] [Related]
23. Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: Possible involvements of the L-arginine-NO pathway and opioid system.
Ulugol A; Dokmeci D; Guray G; Sapolyo N; Ozyigit F; Tamer M
Life Sci; 2006 Feb; 78(14):1592-7. PubMed ID: 16107259
[TBL] [Abstract][Full Text] [Related]
24. Melatonin attenuates the development of antinociceptive tolerance to delta-, but not to mu-opioid receptor agonist in mice.
Dai X; Cui SG; Li SR; Chen Q; Wang R
Behav Brain Res; 2007 Aug; 182(1):21-7. PubMed ID: 17568695
[TBL] [Abstract][Full Text] [Related]
25. Antinociceptive effects of melatonin in a rat model of post-inflammatory visceral hyperalgesia: a centrally mediated process.
Mickle A; Sood M; Zhang Z; Shahmohammadi G; Sengupta JN; Miranda A
Pain; 2010 Jun; 149(3):555-564. PubMed ID: 20413219
[TBL] [Abstract][Full Text] [Related]
26. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
Hamurtekin E; Bagdas D; Gurun MS
Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms involved in the antinociception caused by melatonin in mice.
Mantovani M; Kaster MP; Pertile R; Calixto JB; Rodrigues AL; Santos AR
J Pineal Res; 2006 Nov; 41(4):382-9. PubMed ID: 17014696
[TBL] [Abstract][Full Text] [Related]
28. Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis.
Rosenstein RE; Pandi-Perumal SR; Srinivasan V; Spence DW; Brown GM; Cardinali DP
J Pineal Res; 2010 Aug; 49(1):1-13. PubMed ID: 20492443
[TBL] [Abstract][Full Text] [Related]
29. Melatonin delivery in solid lipid nanoparticles: prevention of cyclosporine A induced cardiac damage.
Rezzani R; Rodella LF; Fraschini F; Gasco MR; Demartini G; Musicanti C; Reiter RJ
J Pineal Res; 2009 Apr; 46(3):255-61. PubMed ID: 19196438
[TBL] [Abstract][Full Text] [Related]
30. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.
Pena-dos-Santos DR; Severino FP; Pereira SA; Rodrigues DB; Cunha FQ; Vieira SM; Napimoga MH; Clemente-Napimoga JT
Neuroscience; 2009 Nov; 163(4):1211-9. PubMed ID: 19647045
[TBL] [Abstract][Full Text] [Related]
31. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
32. Pleiotropic Effects of Melatonin.
Mahmood D
Drug Res (Stuttg); 2019 Feb; 69(2):65-74. PubMed ID: 30060265
[TBL] [Abstract][Full Text] [Related]
33. Antinociceptive properties of the hydroalcoholic extract, fractions and compounds obtained from the aerial parts of Baccharis illinita DC in mice.
Freitas CS; Baggio CH; Dos Santos AC; Mayer B; Twardowschy A; Luiz AP; Marcon R; Soldi C; Pizzolatti MG; Dos Santos EP; Marques MC; Santos AR
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):285-92. PubMed ID: 19281601
[TBL] [Abstract][Full Text] [Related]
34. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events.
Blask DE; Sauer LA; Dauchy RT; Holowachuk EW; Ruhoff MS; Kopff HS
Cancer Res; 1999 Sep; 59(18):4693-701. PubMed ID: 10493527
[TBL] [Abstract][Full Text] [Related]
35. Discovery of 4-aminobutyric acid derivatives possessing anticonvulsant and antinociceptive activities: a hybrid pharmacophore approach.
Yogeeswari P; Ragavendran JV; Sriram D; Nageswari Y; Kavya R; Sreevatsan N; Vanitha K; Stables J
J Med Chem; 2007 May; 50(10):2459-67. PubMed ID: 17451232
[TBL] [Abstract][Full Text] [Related]
36. The antiallodynic effect of Neurotropin is mediated via activation of descending pain inhibitory systems in rats with spinal nerve ligation.
Okazaki R; Namba H; Yoshida H; Okai H; Miura T; Kawamura M
Anesth Analg; 2008 Sep; 107(3):1064-9. PubMed ID: 18713930
[TBL] [Abstract][Full Text] [Related]
37. Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation.
Santoro R; Mori F; Marani M; Grasso G; Cambria MA; Blandino G; Muti P; Strano S
Carcinogenesis; 2013 May; 34(5):1051-61. PubMed ID: 23354312
[TBL] [Abstract][Full Text] [Related]
38. Antinociceptive effects of systemic lidocaine: involvement of the spinal glycinergic system.
Muth-Selbach U; Hermanns H; Stegmann JU; Kollosche K; Freynhagen R; Bauer I; Lipfert P
Eur J Pharmacol; 2009 Jun; 613(1-3):68-73. PubMed ID: 19394327
[TBL] [Abstract][Full Text] [Related]
39. Melatonin inhibits the development of tolerance to U-50,488H analgesia via benzodiazepine-GABAAergic mechanisms.
Dhanaraj E; Nemmani KV; Ramarao P
Pharmacol Biochem Behav; 2004 Dec; 79(4):733-7. PubMed ID: 15582681
[TBL] [Abstract][Full Text] [Related]
40. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans.
Reiter RJ; Tan DX; Mayo JC; Sainz RM; Leon J; Czarnocki Z
Acta Biochim Pol; 2003; 50(4):1129-46. PubMed ID: 14740000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
